About Zydus Lifesciences Limited (ZYDUSLIFE)
Zydus Lifesciences Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Ahmedabad, India. ZYDUSLIFE has been publicly traded since 2000, giving it 26+ years of trading history.
Zydus Lifesciences Limited (ZYDUSLIFE) has been publicly traded since 2000, making it a 26-year-old public company. It operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. The company is headquartered in Ahmedabad, India and employs approximately 27,917 people. With a market capitalization of $912 billion, ZYDUSLIFE is one of the largest publicly traded companies.
ZYDUSLIFE trades on the Indian stock exchanges (NSE/BSE) and is classified as a mega-cap-cap stock with a market capitalization of approximately $912 billion. The company employs approximately 27,917 people worldwide.
Key Statistics
- Current Price
- ₹905.90
- Market Cap
- ₹911.85B
- 52-Week High
- ₹1,059.05
- 52-Week Low
- ₹795.00
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
ZYDUSLIFE Investment Performance
ZYDUSLIFE has declined 0.9% year-to-date in 2026. Over the past 5 years, a $1,000 investment in ZYDUSLIFE would have grown to $2,008, representing a 100.8% total return. Since its IPO in 2000, a $1,000 investment would now be worth $77,241.
₹1,000 Invested in Zydus Lifesciences Limited (ZYDUSLIFE)
How much would ₹1,000 invested in ZYDUSLIFE be worth today?
What would ₹1,000 invested in ZYDUSLIFE 1 year ago be worth today?
A ₹1,000 investment in Zydus Lifesciences Limited (ZYDUSLIFE) in 2025 would be worth ₹1,017 as of May 2026, representing a +1.7% total return.
What would ₹1,000 invested in ZYDUSLIFE 3 years ago be worth today?
A ₹1,000 investment in Zydus Lifesciences Limited (ZYDUSLIFE) in 2023 would be worth ₹1,996 as of May 2026, representing a +99.6% total return.
What would ₹1,000 invested in ZYDUSLIFE 5 years ago be worth today?
A ₹1,000 investment in Zydus Lifesciences Limited (ZYDUSLIFE) in 2021 would be worth ₹2,008 as of May 2026, representing a +100.8% total return.
What would ₹1,000 invested in ZYDUSLIFE 10 years ago be worth today?
A ₹1,000 investment in Zydus Lifesciences Limited (ZYDUSLIFE) in 2016 would be worth ₹2,978 as of May 2026, representing a +197.8% total return.
What would ₹1,000 invested in ZYDUSLIFE at IPO be worth today?
A ₹1,000 investment in Zydus Lifesciences Limited (ZYDUSLIFE) at IPO would be worth ₹77,241 as of May 2026, representing a +7624.1% total return.
Monthly Returns Heatmap
Over the past 25+ years (311 months), Zydus Lifesciences Limited (ZYDUSLIFE) has averaged a monthly return of +1.90% with a median return of +1.31%. The stock had 174 positive months (56%) and 137 negative months (44%). The best month in ZYDUSLIFE's history was May 2000 with a +56.4% return, while the worst was August 2006 at -38.8%. Historically, July tends to be the strongest month (averaging +4.0%), and January the weakest (-2.4%).
ZYDUSLIFE's longest winning streak was 10 consecutive months of gains, while its longest losing streak was 5 consecutive months of losses. The best full year was 2003 with a cumulative return of +135.3%, and the worst was 2019 at -25.5%.
Annual Returns
Over 26 years of trading history, Zydus Lifesciences Limited (ZYDUSLIFE) has delivered an average annual return of +27.33% with a median return of +0.51%. The compound annual growth rate (CAGR) is +17.21%. The stock posted gains in 13 years (50%) and losses in 13 years (50%).
ZYDUSLIFE's best year was 2003 with a +226.52% gain, while the worst was 2006 at -28.21%. The longest streak of consecutive positive years was 4, and the longest losing streak was 4 years. ZYDUSLIFE achieved double-digit gains (10%+) in 10 years. It suffered double-digit losses in 6 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -0.92% | ₹914.35 | ₹905.90 |
| 2025 | -4.82% | ₹960.69 | ₹914.35 |
| 2024 | +41.34% | ₹679.70 | ₹960.69 |
| 2023 | +65.64% | ₹410.33 | ₹679.70 |
| 2022 | -12.46% | ₹468.73 | ₹410.33 |
| 2021 | +1.94% | ₹459.82 | ₹468.73 |
| 2020 | +89.80% | ₹242.26 | ₹459.82 |
| 2019 | -25.89% | ₹326.90 | ₹242.26 |
| 2018 | -18.88% | ₹402.97 | ₹326.90 |
| 2017 | +22.42% | ₹329.17 | ₹402.97 |
| 2016 | +9.92% | ₹299.45 | ₹329.17 |
| 2015 | +3.04% | ₹290.63 | ₹299.45 |
| 2014 | +99.10% | ₹145.97 | ₹290.63 |
| 2013 | -9.29% | ₹160.93 | ₹145.97 |
| 2012 | +29.18% | ₹124.58 | ₹160.93 |
| 2011 | -8.83% | ₹136.65 | ₹124.58 |
| 2010 | +80.76% | ₹75.60 | ₹136.65 |
| 2009 | +146.75% | ₹30.64 | ₹75.60 |
| 2008 | -7.05% | ₹32.96 | ₹30.64 |
| 2007 | -9.07% | ₹36.25 | ₹32.96 |
| 2006 | -28.21% | ₹50.49 | ₹36.25 |
| 2005 | -15.48% | ₹59.74 | ₹50.49 |
| 2004 | +54.46% | ₹38.67 | ₹59.74 |
| 2003 | +226.52% | ₹11.84 | ₹38.67 |
| 2002 | -3.21% | ₹12.24 | ₹11.84 |
| 2001 | -16.14% | ₹14.59 | ₹12.24 |
ZYDUSLIFE Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Zydus Lifesciences Limited as an investment
Valuation
ZYDUSLIFE currently trades at a trailing P/E ratio of 18.5, which is considered moderate relative to the broader market. The forward P/E of 21.8 suggests analysts expect earnings to be higher in the coming year. The price-to-book ratio stands at 3.6. The price-to-sales ratio is 3.5.
Dividends
Zydus Lifesciences Limited pays a dividend to shareholders with a current yield of 1.21%. This translates to $11.00 per share annually. The payout ratio of 22% indicates sustainable dividend coverage.
Risk & Volatility
ZYDUSLIFE has a beta of 0.37, indicating it is less volatile than the overall market. The stock's 52-week range is $795.00 to $1059.05, and it currently trades in the lower half of its 52-week range.
Analyst Ratings
Based on 30 analyst opinions, ZYDUSLIFE has a consensus "hold" rating. The average price target of $993.73 suggests 9.7% upside from current levels.
Frequently Asked Questions: ZYDUSLIFE
What sector is ZYDUSLIFE in? ▼
ZYDUSLIFE operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has ZYDUSLIFE performed historically? ▼
Over 26 years of trading history, ZYDUSLIFE has posted gains in 13 years (50% of the time). The best year was 2003 with a +226.5% return. Past performance does not guarantee future results.
How can I invest in ZYDUSLIFE? ▼
You can invest in ZYDUSLIFE through any brokerage account that offers access to Indian exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold ZYDUSLIFE.
Does ZYDUSLIFE pay dividends? ▼
Zydus Lifesciences Limited pays a dividend to shareholders with a current yield of 1.21%. This translates to $11.00 per share annually. The payout ratio of 22% indicates sustainable dividend coverage.
What does Zydus Lifesciences Limited do? ▼
Zydus Lifesciences Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Ahmedabad, India.
What sector is ZYDUSLIFE in? ▼
ZYDUSLIFE operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
When did ZYDUSLIFE go public? ▼
Zydus Lifesciences Limited went public in 2000, making it a 26-year-old public company as of 2026.
How much would $1,000 invested in ZYDUSLIFE 5 years ago be worth today? ▼
A $1,000 investment in ZYDUSLIFE five years ago would be worth approximately $2,008 today, representing a 100.8% return.
Does ZYDUSLIFE pay dividends? ▼
Yes, Zydus Lifesciences Limited pays a dividend with a current yield of 1.21%, which is $11.0 per share annually.
What is ZYDUSLIFE's market cap? ▼
Zydus Lifesciences Limited has a market capitalization of $912 billion, classifying it as a mega-cap company.
What is ZYDUSLIFE's P/E ratio? ▼
ZYDUSLIFE has a trailing P/E ratio of 18.5 and a forward P/E of 21.8, which measures how much investors are paying per dollar of earnings.
Is ZYDUSLIFE a buy, hold, or sell? ▼
Based on 30 opinions, ZYDUSLIFE has a consensus "hold" rating. The average price target is $993.73.
Last updated: 3/14/2026